Updated Jul 16, 2026
EMALFARB MARK A is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Mark A. Emalfarb is the CEO, 10% owner, and a director of Dyadic International Inc, a biotechnology platform company focused on gene expression technology. He has been involved in the company's operations and strategic direction, particularly in licensing their technology for industrial applications.
| Role | CEO, Director, 10% Owner |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-06 | DYAI | DYADIC INTERNATIONAL INC | A — Grant or award | 102.6K | $0.00 |
Mark A. Emalfarb is the CEO, 10% owner, and a director of Dyadic International Inc, a biotechnology platform company focused on gene expression technology. He has been involved in the company's operations and strategic direction, particularly in licensing their technology for industrial applications.…
Recorded transactions: 1 open-market purchases () and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live EMALFARB MARK A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.